Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hikal, an outsourcing partner for pharmaceuticals, biotech, agrochemicals and speciality chemicals industries, has announced the commencement of operations at active pharmaceutical ingredients (APIs) manufacturing facility by June 2012.
Subscribe to our email newsletter
The company will supply a range of APIs from its Bangalore facility to its customers in markets like the US, Europe, South East Asia, Latin America, Canada and Japan.
The new multipurpose API facility at Jigani near Bangalore, India, would meet additional demands from its US, European and Japanese customers, the company said.
The plant can accommodate 32 reactors with capacities ranging from 6 m3 to 10 m3, which will result in a total reactor volume of approximately 300m3.
The company has appointed Peter Nightingale as the president of its 100% contract research subsidiary, Acoris Research, Pune, India.
Hikal vice chairman and managing director Jai Hiremath told Business-Standard that Dr Nightingale’s experience in the adaptation of new technologies in chemistry will be a great asset to Acoris.